Tarsier Pharma

Tarsier Pharma is dedicated to pioneering a paradigm shift in the treatment of ocular diseases through innovative pharmaceutical manufacturing. With a focus on ocular inflammatory blinding diseases, particularly uveitis, Tarsier Pharma is committed to developing novel treatments that improve patient outcomes and enhance quality of life. Located in Zichron Yaacov, Israel, Tarsier Pharma operates from its primary address at Zichron Yaacov, 30900, IL, driving advancements in pharmaceutical solutions for eye health.

Tarsier Pharma is focused on research and development to address critical needs in the field of ophthalmology. Through dedication and expertise, Tarsier Pharma aims to introduce groundbreaking therapies that set new standards in ocular disease management. The company's commitment to innovation positions it as a key player in the pharmaceutical sector.

Tarsier Pharma’s ongoing work will soon be complemented with detailed information about their therapeutic breakthroughs, available through the support of the company’s management. We invite the manager of Tarsier Pharma to create a customized and exclusive company showcase and product listing on our platform to highlight your innovative contributions to the pharmaceutical industry.